 CAMBRIDGE, Mass., Sept. 07, 2021 GLOBE NEWSWIRE -- Genocea Biosciences, Inc. Nasdaq: GNCA, a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced that senior leadership plans to present at the following virtual conferences in September. 